ICD-10, see below B65 B78 A06 B74.9 B66.3 B53 B55 B66.4
Conditions
Interventions
Group 1: stored sera collected from individuals tested for schistosomiasis, strongyloidiasis, amoebiasis, filariasis, fascioliasis, malaria, leishmaniasis and paragonimiasis at the Department for Infe
Sponsors
Universitätsklinikum Heidelberg, Abteilungen für Infektions- und Tropenmedizin, Parasitologie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Sera of patients known to be positive for schistosomiasis, strongyloidiasis, amoebiasis, filariasis, fascioliasis, malaria, leishmaniasis or paragonimiasis - Serological control group sera of patients known to be negative for respective pathogens
Exclusion criteria
Exclusion criteria: • No specific exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.1 Determine diagnostic accuracy of commercial serological tests for schistosomiasis, strongyloidiasis, amoebiasis, filariasis, fascioliasis, malaria, leishmaniasis or paragonimiasis using microscopy and molecular assays as reference standard 1.2. Determine diagnostic accuracy of commercial serological tests for schistosomiasis, strongyloidiasis, amoebiasis, filariasis, fascioliasis, malaria, leishmaniasis or paragonimiasis using microbiological tests as reference standard and in-house serology as comparator | — |
Secondary
| Measure | Time frame |
|---|---|
| 2.1 evaluate PCRs on serum of patients known to be infected for schistosomiasis for diagnostic accuracy 2.2 evaluate PCRs on serum of patients known to be infected and treated for schistosomiasis for changes from baseline during treatment | — |
Countries
Germany
Contacts
Public ContactClaudia Denkinger
Universitätsklinikum Heidelberg
Outcome results
None listed